BRPI0408569A - processo para preparação de ciclesonida cristalina com tamanho de partìcula definido - Google Patents

processo para preparação de ciclesonida cristalina com tamanho de partìcula definido

Info

Publication number
BRPI0408569A
BRPI0408569A BRPI0408569-8A BRPI0408569A BRPI0408569A BR PI0408569 A BRPI0408569 A BR PI0408569A BR PI0408569 A BRPI0408569 A BR PI0408569A BR PI0408569 A BRPI0408569 A BR PI0408569A
Authority
BR
Brazil
Prior art keywords
particle size
defined particle
preparing crystalline
crystalline ciclesonide
ciclesonide
Prior art date
Application number
BRPI0408569-8A
Other languages
English (en)
Inventor
Klaus Eistetter
Stefan Kaupp
Ernst Sturm
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33099298&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0408569(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of BRPI0408569A publication Critical patent/BRPI0408569A/pt
Publication of BRPI0408569B1 publication Critical patent/BRPI0408569B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F21/00—Dissolving

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"PROCESSO PARA PREPARAçãO DE CICLESONIDA CRISTALINA COM TAMANHO DE PARTìCULA DEFINIDO". A presente invenção refere-se a um novo processo para a preparação de ciclesonida cristalina com um tamanho de partícula vantajoso e ao emprego para produção de preparações farmacêuticas, em particular para emprego tópico. A ciclesonida cristalina obtida pelo novo processo tem propriedades aerodinâmicas vantajosas, e pode ser processada também para preparações farmacêuticas nasalmente administradas ou inaláveis ou sem micronização mecânica adicional.
BRPI0408569-8A 2003-03-27 2004-03-26 Method for preparing a formula i compound in the crystalline form BRPI0408569B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP03007007 2003-03-27
DE10314097.2 2003-03-27
DE10314097 2003-03-27
EP03007007.2 2003-03-27
PCT/EP2004/050373 WO2004085460A1 (en) 2003-03-27 2004-03-26 Process for preparing crystalline ciclesonide with defined particle size

Publications (2)

Publication Number Publication Date
BRPI0408569A true BRPI0408569A (pt) 2006-03-21
BRPI0408569B1 BRPI0408569B1 (pt) 2017-08-29

Family

ID=33099298

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0408569-8A BRPI0408569B1 (pt) 2003-03-27 2004-03-26 Method for preparing a formula i compound in the crystalline form

Country Status (27)

Country Link
US (1) US9422327B2 (pt)
EP (1) EP1611150B1 (pt)
JP (1) JP4746535B2 (pt)
KR (1) KR101102709B1 (pt)
AR (1) AR043579A1 (pt)
AT (1) ATE546459T1 (pt)
AU (1) AU2004224092B2 (pt)
BR (1) BRPI0408569B1 (pt)
CA (1) CA2519752C (pt)
CL (1) CL2004000636A1 (pt)
CY (1) CY1112970T1 (pt)
DK (1) DK1611150T3 (pt)
EA (1) EA011157B1 (pt)
ES (1) ES2382928T3 (pt)
HR (1) HRP20050917B1 (pt)
IL (1) IL170746A (pt)
MX (1) MXPA05010041A (pt)
MY (1) MY143936A (pt)
NO (1) NO331984B1 (pt)
NZ (1) NZ542827A (pt)
PE (1) PE20050388A1 (pt)
PL (1) PL1611150T3 (pt)
PT (1) PT1611150E (pt)
RS (1) RS52549B (pt)
SI (1) SI1611150T1 (pt)
TW (1) TWI328589B (pt)
WO (1) WO2004085460A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US20070135398A1 (en) * 2005-11-02 2007-06-14 Pierluigi Rossetto Process for the preparation of ciclesonide
EP1904514A2 (en) * 2006-02-08 2008-04-02 Sicor, Inc. Crystalline forms of ciclesonide
WO2008015696A2 (en) * 2006-05-23 2008-02-07 Cadila Healthcare Limited Process for preparing ciclesonide
WO2008062450A2 (en) * 2006-09-18 2008-05-29 Cadila Healthcare Limited Crystalline polymorphs of ciclesonide
CA2663737A1 (en) * 2006-09-19 2008-03-27 Cipla Limited Processes for the preparation of ciclesonide and its crystal form
EP2262823B1 (en) * 2008-03-13 2013-01-23 Farmabios S.p.A. Process for the preparation of pregnane derivatives
IT1397499B1 (it) * 2009-01-09 2013-01-16 Farmabios Spa Processo per la preparazione di ciclesonide
WO2010054158A2 (en) * 2008-11-07 2010-05-14 Auspex Pharmaceuticals, Inc. Steroid modulators of glucocorticoid receptor
US9109005B2 (en) 2012-02-23 2015-08-18 Boehringer Ingelheim International Gmbh Method for manufacturing of ciclesonide
US20150165037A1 (en) 2012-07-05 2015-06-18 Arven llac Sanayi Ve Ticaret A.S. Inhalation compositions comprising corticosteroid and sorbitol
WO2014007772A2 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising glucose anhydrous
US20150224197A1 (en) 2012-07-05 2015-08-13 Arven Ilac Sanayi Ve Ticaret A.S. Inhalation compositions
PE20190622A1 (es) 2016-06-02 2019-04-26 Abbvie Inc Agonista del receptor de glucocorticoides e inmunoconjugados del mismo
MA49796A (fr) 2017-12-01 2020-06-03 Abbvie Inc Agoniste du récepteur des glucocorticoïdes et immunoconjugués de celui-ci

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8328929D0 (en) * 1983-10-29 1983-11-30 Sterwin Ag Steroid compounds
AU624421B2 (en) 1988-10-05 1992-06-11 Pharmacia & Upjohn Company Finely divided solid crystalline powders via precipitation into an anti-solvent
ES2060040T5 (es) 1989-05-31 1999-09-16 Fisons Plc Dispositivo y formulacion de inhalacion de medicamento.
GR1001529B (el) 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
FR2668945B1 (fr) 1990-11-12 1993-02-19 Theramex Nouveau procede de cristallisation des substances organiques et les composes ainsi obtenus.
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
GB9213874D0 (en) 1992-06-30 1992-08-12 Fisons Plc Process to novel medicament form
GB9306703D0 (en) 1993-03-31 1993-05-26 Fisons Plc Inhalation device
ATE172739T1 (de) * 1993-04-02 1998-11-15 Byk Gulden Lomberg Chem Fab Neue prednisolonderivate
IL111194A (en) 1993-10-08 1998-02-08 Fisons Plc Process for the production of medicament formulations
DK0749438T3 (da) * 1994-03-09 2001-04-02 Byk Gulden Lomberg Chem Fab Hidtil ukendte silylforbindelser og deres anvendelse
DE19541689A1 (de) 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
DE19635498A1 (de) * 1996-09-03 1998-03-26 Byk Gulden Lomberg Chem Fab Verfahren zur Epimerenanreicherung
US6120752A (en) * 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
GB9722285D0 (en) 1997-10-23 1997-12-17 Rhone Poulenc Rorer Ltd Inhalation device
US6264923B1 (en) * 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
ATE283033T1 (de) * 1998-07-24 2004-12-15 Jago Res Ag Medizinische aerosolformulierungen
GB9828721D0 (en) 1998-12-24 1999-02-17 Glaxo Group Ltd Novel apparatus and process
ATE304799T1 (de) * 1999-06-25 2005-10-15 Cognis Ip Man Gmbh Verwendung von nanoskaligen sterolen und sterolestern
AR026072A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
EA006231B1 (ru) * 2000-11-10 2005-10-27 Алтана Фарма Аг Способ получения 16,17-[(циклогексилметилен)бис(окси)]-11,21-дигидроксипрегна-1,4-диен-3,20-диона или его 21-изобутирата транскетализацией

Also Published As

Publication number Publication date
PL1611150T3 (pl) 2012-07-31
EP1611150A1 (en) 2006-01-04
DK1611150T3 (da) 2012-05-14
NO20054835L (no) 2005-10-19
HRP20050917A2 (en) 2006-12-31
WO2004085460A1 (en) 2004-10-07
IL170746A0 (en) 2009-02-11
HRP20050917B1 (hr) 2014-02-14
TWI328589B (en) 2010-08-11
AR043579A1 (es) 2005-08-03
US9422327B2 (en) 2016-08-23
CA2519752A1 (en) 2004-10-07
CY1112970T1 (el) 2016-04-13
RS20050704A (sr) 2007-06-04
KR20050114250A (ko) 2005-12-05
JP2006521332A (ja) 2006-09-21
EA011157B1 (ru) 2009-02-27
AU2004224092B2 (en) 2010-03-04
EA200501391A1 (ru) 2006-06-30
US20060128954A1 (en) 2006-06-15
PE20050388A1 (es) 2005-05-30
ATE546459T1 (de) 2012-03-15
NZ542827A (en) 2008-02-29
CA2519752C (en) 2012-05-29
EP1611150B1 (en) 2012-02-22
PT1611150E (pt) 2012-05-07
ES2382928T3 (es) 2012-06-14
BRPI0408569B1 (pt) 2017-08-29
NO331984B1 (no) 2012-05-21
MXPA05010041A (es) 2005-11-17
RS52549B (sr) 2013-04-30
MY143936A (en) 2011-07-29
HK1088905A1 (zh) 2006-11-17
WO2004085460A8 (en) 2007-03-15
AU2004224092A1 (en) 2004-10-07
IL170746A (en) 2012-06-28
JP4746535B2 (ja) 2011-08-10
SI1611150T1 (sl) 2012-06-29
KR101102709B1 (ko) 2012-01-05
CL2004000636A1 (es) 2005-02-04
TW200418519A (en) 2004-10-01

Similar Documents

Publication Publication Date Title
BR0112918A (pt) Composto, utilização do mesmo, processo de tratamento de distúrbios, processo para a preparação de composto, composição farmacêutica que compreende esse composto, processo para preparar uma composição e processo de tratamento de obesidade em um ser humano
BR0116201A (pt) Composto, processo para a preparação de um composto, composição farmacêutica que compreende o composto, utilização do composto, processo para o tratamento e profilaxia de distúrbios e para o tratamento de obesidade
BR0203785A (pt) ácido silìcico precipitante com elevada proporção bet/ctab
CA2436540A1 (en) Pharmaceutical compositions based on anticholinergics and corticosteroids
ATE544445T1 (de) Herstellung von sterilen wässrigen suspensionen mit mikronisierten kristallinen wirkstoffen zur inhalation
WO2002047668A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und ciclesonide
CY1112970T1 (el) Μεθοδος παρασκευης κρυσταλλικης κικλεζονιδης με καθορισμενο μεγεθος σωματιδιων
BR0213380A (pt) Derivados propiÈnicos alfa-oxissubstituìdos por beta-fenila: processo para sua preparação e seu uso na preparação de compostos farmaceuticamente importantes
MX2009004690A (es) Sistema y proceso para producir una solucion de solidos poco suspendidos y usos de la misma.
WO2002060435A8 (fr) Cryptotanshinone permettant de prevenir et d'attenuer la maladie d'alzheimer
CN101474284B (zh) 一种治疗真菌性皮肤病的外用药
CN105770375A (zh) 一种伊贝母提取物的制备方法和用途
WO2003018568A3 (en) Ascorbic acid derivatives, methods of synthesis and pharmaceutical use thereof
PT1198224E (pt) Formulacoes de solucoes de esteroides para administracao por inalacao
PL353992A1 (en) 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use
CA2436537A1 (en) Pharmaceutical compositions comprising tiotropium salts and antihistamines
CN106632031A (zh) 一种地喹氯铵晶体及其含片和含片的制备方法
CN101456842A (zh) 磷酸高乌甲素的合成方法
MXPA05011591A (es) Composicion farmaceutica como forma de dosificacion solida y metodo para la elaboracion de la misma.
BR0008520A (pt) Modificação de cristal d de ácido8-ciano-1-ciclopropil-7-(1s,6s-2,8-diazabiciclo[4.3.0]nonan-8-il)-6-flúor-1,4-dihidro-4-oxo-3quinolincarboxìlico
BRPI0413458A (pt) compostos, processo para a sua preparação, composição farmacêutica que compreende os mesmos, utilização de um composto, métodos para o tratamento e profilaxia de artrite, diabetes, distúrbios alimentares e obesidade
CN102688330A (zh) 一种生物中药药膜及其制备方法
JP2518704B2 (ja) システイン酸亜鉛、その製造方法並びに医薬及び化粧品への用途
AU2018101120A4 (en) Drug intermediates 1,4,9(11)-pregnenetriene-16α-methyl-17α,21-diol-3,20- dione-21-acetate synthesis method
CN109276633A (zh) 一种缓解骨质增生用软膏剂

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: NYCOMED GMBH (DE)

Free format text: ALTERADO DE: ALTANA PHARMA AG

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25D Requested change of name of applicant approved

Owner name: TAKEDA GMBH (DE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: NYCOMED ASSET MANAGEMENT GMBH (DE)

B25A Requested transfer of rights approved

Owner name: NYCOMED GERMANY HOLDING GMBH (DE)

B25D Requested change of name of applicant approved

Owner name: TAKEDA GMBH (DE)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: ASTRAZENECA AB (SE)

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B25A Requested transfer of rights approved
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 26/03/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF